These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 11498771

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
    Zhang F, Lu W, Dong Z.
    Clin Cancer Res; 2002 Sep; 8(9):2942-51. PubMed ID: 12231540
    [Abstract] [Full Text] [Related]

  • 3. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
    Lee J, Wang A, Hu Q, Lu S, Dong Z.
    Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 5. Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus-mediated interferon beta gene therapy.
    Lu W, Fidler IJ, Dong Z.
    Cancer Res; 1999 Oct 15; 59(20):5202-8. PubMed ID: 10537298
    [Abstract] [Full Text] [Related]

  • 6. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.
    Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W, Bucana CD, Balbay MD, Bielenberg D, Fidler IJ.
    Cancer Res; 1999 Feb 15; 59(4):872-9. PubMed ID: 10029078
    [Abstract] [Full Text] [Related]

  • 7. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 8. Regression of primary murine colon cancer and occult liver metastasis by intralesional injection of lyophilized preparation of insect cells producing murine interferon-beta.
    Ozawa S, Lu W, Bucana CD, Kanayama HO, Shinohara H, Fidler IJ, Dong Z.
    Int J Oncol; 2003 May 15; 22(5):977-84. PubMed ID: 12684662
    [Abstract] [Full Text] [Related]

  • 9. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma.
    Wang B, Xiong Q, Shi Q, Le X, Abbruzzese JL, Xie K.
    Cancer Res; 2001 Jan 01; 61(1):71-5. PubMed ID: 11196200
    [Abstract] [Full Text] [Related]

  • 10. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.
    Kim SJ, Uehara H, Karashima T, Shepherd DL, Killion JJ, Fidler IJ.
    Clin Cancer Res; 2003 Mar 01; 9(3):1200-10. PubMed ID: 12631626
    [Abstract] [Full Text] [Related]

  • 11. Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy.
    Olson MV, Lee J, Zhang F, Wang A, Dong Z.
    Cancer Gene Ther; 2006 Jul 01; 13(7):676-85. PubMed ID: 16470211
    [Abstract] [Full Text] [Related]

  • 12. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide.
    Xie K, Bielenberg D, Huang S, Xu L, Salas T, Juang SH, Dong Z, Fidler IJ.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2283-94. PubMed ID: 9815626
    [Abstract] [Full Text] [Related]

  • 13. Regulation of TGF-beta1 gene transcription in human prostate cancer cells by nitric oxide.
    Wang D, Lu S, Dong Z.
    Prostate; 2007 Dec 01; 67(16):1825-33. PubMed ID: 17941092
    [Abstract] [Full Text] [Related]

  • 14. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T, Lin FF, Rao P, Lin MF.
    Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404
    [Abstract] [Full Text] [Related]

  • 15. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
    Tai KF, Chen PJ, Chen DS, Hwang LH.
    J Gene Med; 2003 May 01; 5(5):386-98. PubMed ID: 12731087
    [Abstract] [Full Text] [Related]

  • 16. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 01; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha.
    Miyake K, Tsuchida K, Sugino H, Imura S, Morine Y, Fujii M, Shimada M.
    Cancer Chemother Pharmacol; 2007 Jan 01; 59(1):113-26. PubMed ID: 16699793
    [Abstract] [Full Text] [Related]

  • 18. Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
    Inoue K, Perrotte P, Wood CG, Slaton JW, Sweeney P, Dinney CP.
    Clin Cancer Res; 2000 Nov 01; 6(11):4422-31. PubMed ID: 11106263
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.